Enhanced bimatoprost ophthalmic solution
US8933127B2 · kind B2 · utility
3Cited by
31References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 17, 2012 |
| Grant date | Jan 13, 2015 |
| Priority date | — |
| Expiry date | Jul 25, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein. A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.